Clinical trial
Effect of Dihydrotestosterone (DHT) on Prostate Tissue [Short Title: DHT-3]
NCT00490022 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00490022 |
|---|---|
| Title | Effect of Dihydrotestosterone (DHT) on Prostate Tissue [Short Title: DHT-3] |
| Official title | The Effect of Dihydrotestosterone (DHT) on Prostate Tissue Androgen Concentrations and Inflammation in Normal Men |
| Acronym | DHT-3 |
| Lead sponsor | University of Washington, Other |
| Collaborators | National Institute on Aging (NIA) NIH ASCEND Therapeutics Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Dihydrotestosterone (DHT) gel (0.7%), Placebo gel |
| Enrollment | 31 |
| Start date | Jun 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Jun 22, 2007 |
| Last update posted | Jun 27, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: